M. Budde
Impact in
- Oncology top 5%
- Bone health and treatments
- Cancer Diagnosis and Treatment
- Polyomavirus and related diseases
- Transplantation top 5%
Papers in ⓘ
-
- Statistical Methods in Clinical Trials 7
-
- Acute Myeloid Leukemia Research 6
- Co-authors
- Vincent Charlon (1 shared paper)Reuven J. Viskoper (1 shared paper)Henry Krum (1 shared paper)Yves Lacourcière (1 shared paper)B. Bergström (6 shared papers)М. Р. Личиницер (3 shared papers)Jean‐Jacques Body (3 shared papers)W. Dornoff (2 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Pharmaceutical Statistics (2 papers)Journal of the American Statistical Association (2 papers)Annals of Oncology (2 papers)Cancer (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
M. Budde
27 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 88
- Oncology 633
- Transplantation 56
- Orthopedics and Sports Medicine 127
- Cardiology and Cardiovascular Medicine 321
- Hematology 149
Countries citing papers authored by M. Budde
This map shows the geographic impact of M. Budde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Budde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Budde more than expected).
Fields of papers citing papers by M. Budde
This network shows the impact of papers produced by M. Budde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Budde. The network helps show where M. Budde may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Budde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 449 | |
| 2 | 2003 | 296 | |
| 3 | 2005 | 179 | |
| 4 | 2004 | 112 | |
| 5 | 1987 | 84 | |
| 6 | 2000 | 73 | |
| 7 | 2004 | 68 | |
| 8 | 1989 | 30 | |
| 9 | 1986 | 15 | |
| 10 | 1987 | 13 | |
| 11 | 1998 | 12 | |
| 12 | 2005 | 11 | |
| 13 | 2004 | 11 | |
| 14 | 1994 | 10 | |
| 15 | 2003 | 7 | |
| 16 | 2004 | 5 | |
| 17 | 2004 | 5 | |
| 18 | 1989 | 4 | |
| 19 | 1987 | 4 | |
| 20 | 1991 | 3 |
About M. Budde
M. Budde is a scholar working on Statistics and Probability, Hematology, Transplantation, Oncology and Orthopedics and Sports Medicine, having authored 27 papers that have together received 1.4k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (7 papers), Bone health and treatments (7 papers), Acute Myeloid Leukemia Research (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Bone health and osteoporosis research (3 papers), Medical Imaging and Pathology Studies (3 papers) and Optimal Experimental Design Methods (3 papers). The work is most often cited by research in Oncology (633 citations), Transplantation (56 citations), Orthopedics and Sports Medicine (127 citations), Cardiology and Cardiovascular Medicine (321 citations) and Hematology (149 citations). M. Budde has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Vincent Charlon, Reuven J. Viskoper, Henry Krum, Yves Lacourcière, B. Bergström, М. Р. Личиницер, Jean‐Jacques Body, W. Dornoff, Ingo Diel and В. А. Горбунова. Their work appears in journals such as Journal of Clinical Oncology, Pharmaceutical Statistics, Journal of the American Statistical Association, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.